Go Back
Image

Dr. Kevin Stevenson, FACHE

Director of Strategic Operations (Administration) Providence Healthcare Network
Subscribe

Behind the Clinical Trials for Non-Alcohol Fatty Liver Disease that Can Benefit 30% of Americans

 

The Impact Research Institute (IRI) is Waco, Texas’ resource for extending care options for NAFLD (non-alcohol fatty liver disease.) Nadege Gunn is IRI’s Medical Director and President. She joined Kevin Stevenson on I Don’t Care to discuss her and her team’s mission to treat NAFLD and other related diseases and conditions.

Dr. Gunn is a Gastroenterologist and Hepatologist whose main passion is the liver. “The liver is an amazing organ,” Dr. Gunn said. “It’s the only organ in the body that you could cut in half, and it can grow back in full size in about three months. The work we do in transplantation and replacing the liver is quite amazing, so that’s why I chose the field in general.”

Dr. Gunn helped open IRI in July of 2021. Necessity created the decision to develop the center. While practicing clinical trials in Austin, Texas, Dr. Gunn saw many patients traveling from the Waco area to receive treatment options for NAFLD. With no scan or clinical trial options available to people in Waco and the surrounding area, Dr. Gunn recognized an opportunity to open a clinic to serve the growing needs.

Community outreach is critical to the clinic’s role in Waco, TX. When they identify candidates who may have NAFLD, they do a non-invasive scan at the center to determine if the candidate does have the disease. “If they do, then we invite them to maybe participate in a clinical trial because there are no treatments for fatty liver,” Dr. Gunn said.

For people wondering if they might have NAFLD, Dr. Gunn said the disease is often asymptomatic in the early stages. “It is when the disease is progressing, when it is starting to injure and harm the liver, that people might start firstly feeling fatigued,” Dr. Gunn said. “They might feel pain in the right upper quadrant of their abdomen and their belly.” Recognizing these warning signs and seeking a diagnosis is critical before full-on cirrhosis of the liver occurs.

More Like This Story:

Providing Real-Time Feedback for Virtual Health

Tearing Down the Barrier of Prior Authorization Through Automation

Fields with ( * ) are required

To submit a comment, please provide your name and email or sign in at MarketScale.com

200

Recent Posts

cancer diagnoses
Rising Cancer Diagnoses in Young Adults: Lifestyle Changes and Early Screenings can Lower Risks Healthcare - Jun 7, 2024

In recent years, a troubling trend has emerged: a noticeable rise in cancer diagnoses among young adults. This discussion is particularly timely following the news of Princess Kate Middleton’s cancer diagnosis and the growing recognition that cancer is no longer a disease confined to older populations. Research indicates that environmental and behavioral factors, alongside…

survivors
Empowering Survivors: Sophia Strother-Lewis’s Journey from Abuse to Advocacy and Entrepreneurship Healthcare - Jun 7, 2024

In this powerful episode of “I Don’t Care,” Dr. Kevin Stevenson sits down with Sophia Strother-Lewis to explore her incredible journey from a traumatic childhood to becoming a successful entrepreneur and advocate for survivors. This conversation is especially timely as awareness about human trafficking and sexual abuse continues to grow, highlighting the need for more…

HVAC systems in healthcare
Optimizing Healthcare Spaces: Trane’s Innovative Approach . Healthcare - Jun 7, 2024

As healthcare facilities continue to evolve, maintaining optimal environmental conditions becomes increasingly critical for patient safety and comfort. With healthcare-associated infections affecting 1 in 31 patients on any given day, ensuring proper air quality and temperature control is more important than ever. HVAC systems in healthcare settings play a crucial role in clinical operations,…

Register to MarketScale.com for Kevin Stevenson episodes, events, and more.


Already have an account?